05:26 AM EDT, 03/20/2024 (MT Newswires) -- Steve Elms, Director, around March 18, 2024, sold 461,716 shares in Adma Biologics ( ADMA ) for $2,803,741. Following the Form 4 filing with the SEC, Elms has control over a total of 2,192,112 shares of the company, with 76,441 shares held directly and 2,115,671 shares controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1368514/000114036124014226/xslF345X03/form4.xml